<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104108">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01793961</url>
  </required_header>
  <id_info>
    <org_study_id>5331</org_study_id>
    <secondary_id>2012-A00991-42</secondary_id>
    <nct_id>NCT01793961</nct_id>
  </id_info>
  <brief_title>Effects of Chronic Intake of Cannabis on Contrast Sensitivity</brief_title>
  <official_title>Effects of Chronic Intake of Cannabis on Contrast Sensitivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rates of driving under the influence of cannabis have risen in recent years. Cannabis is
      involved in 1/3 of motor vehicle collisions. The chronic use of cannabis is known to affect
      dopaminergic regulation and may thus impair contrast sensitivity. In turn, contrast
      sensitivity disorders could originate difficulties to anticipate and avoid collision with
      objects, especially when objects are in movement. The investigators goal is to examine the
      effects of a chronic intake of cannabis on contrast sensitivity. The observed values will be
      compared to standard references. In addition, since smoking cannabis is always associated
      with tobacco, the investigators will  control the effects of tobacco on contrast
      sensitivity.

      In this study, the investigators will include 36 cannabis addicts, 36 tobacco addicts and 36
      no smokers. The investigators will present gratings with different spatial frequencies and
      the investigators will determine contrast thresholds for static and dynamic (moving)
      gratings. The investigators predict that cannabis addicts will present abnormal contrast
      sensitivity especially in case of dynamic presentation of gradings.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2013</start_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>The contrast detection treshold</measure>
    <time_frame>up to 9 days after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of the contrast detection threshold of the 3 groups</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Chronic Intake of Cannabis.</condition>
  <arm_group>
    <arm_group_label>&quot;Cannabis&quot; Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient addicted to cannabis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Tobacco&quot; Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient addicted to tobacco</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Healthy volunteers&quot;</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>no smokers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>electroretinogram</intervention_name>
    <arm_group_label>&quot;Cannabis&quot; Arm</arm_group_label>
    <arm_group_label>&quot;Tobacco&quot; Arm</arm_group_label>
    <arm_group_label>&quot;Healthy volunteers&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>contrast sensitivity tests</intervention_name>
    <arm_group_label>&quot;Cannabis&quot; Arm</arm_group_label>
    <arm_group_label>&quot;Tobacco&quot; Arm</arm_group_label>
    <arm_group_label>&quot;Healthy volunteers&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        &quot;Cannabis&quot; Arm

          -  patient addicted to cannabis

          -  Positive CAST test result

          -  Urine tested positive for cannabis metabolites

        &quot;Tobacco&quot; Arm

          -  positive Fagerström test result

          -  No cannabis intake in the last year before inclusion

          -  No previous history of cannabis use

        &quot;Healthy Volunteers&quot;

          -  No tobacco or cannabis intake in the last year before inclusion

          -  No history of addictive disorders

        Exclusion Criteria:

          -  addiction to other substances than cannabis or tobacco

          -  benzodiazepine treatment

          -  patient with history of benzodiazepine treatment

          -  patient with history of general anesthesia in the last 3 months before inclusion

          -  patient with history of head trauma

          -  Pregnant woman

          -  breast feeding woman

          -  Adults under supervision or guardianship
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurence Lalanne-Tongio, MD</last_name>
    <email>Laurence.lalanne@chru-strasbourg.fr</email>
  </overall_contact>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 15, 2013</lastchanged_date>
  <firstreceived_date>February 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
